Contract award

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is delighted to announce that it has been awarded a contract by a new UK based biotech client.  The value of the contract is £48k and it is expected to complete in this calendar year.

Click here to read in full.